Joel Marcus, chairman at Alexandria Real Estate Equities, discusses the risk of rising interest rates, how government action on drug pricing could impact the firm’s pharmaceutical tenants, and exploring opportunities in the agriculture technology sector. He speaks with Bloomberg’s Erik Schatzker from the Robin Hood Investors Conference on “Bloomberg Markets.”
{iframe}https://www.bloomberg.com/news/videos/2018-10-29/alexandria-real-estate-s-marcus-on-interest-rates-drug-pricing-video{/iframe}